Headquartered in Guilford, CT, AlphaMeld® Corporation (a wholly owned subsidiary of InveniAI LLC) stands as a global frontrunner in the application of AI, machine learning, and generative AI tools, catalyzing innovation throughout drug discovery and development. With a mission to identify and expedite transformative therapies for diseases with unmet medical needs, the company utilizes its cutting-edge AlphaMeld platform to extract valuable insights from petabytes of diverse data sets, propelling the creation of groundbreaking drug programs. The company's pioneering approach is underscored by successful collaborations with industry leaders and drug spinouts, solidifying its position as a trailblazer in the realm of AI-driven drug discovery.
About The AlphaMeld® Platform
The AlphaMeld platform employs a comprehensive approach to generate testable hypotheses, considering factors such as the ideal mode of pharmacotherapy, disease severity, gene ontology, disease pathways, proteinopathies, standard of care, emerging innovation, and enabling technologies. This is done while factoring in medical, scientific, strategic, and commercial considerations.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 2614 Boston Post Rd, Guilford,connecticut 06437,united States
- Industry
- Information Technology & Services
- Website
- inveniai.com
- Keywords
- Artificial Intelligence, Big Data Analytics, Deep Machine Learning, Drug Discovery, Innovation Monitoring, Innovation Scanning, Predictive Analytics.
- HQ
- Guilford, Connecticut
Alphameld Corporation Questions
Alphameld Corporation's website is inveniai.com
Alphameld Corporation's LinkedIn profile is https://www.linkedin.com/company/alphameld
Alphameld Corporation has
25 employees.
View email and phone details for 25
employees at Alphameld Corporation.
Alphameld Corporation's industry is
Information Technology & Services
Alphameld Corporation's top competitors are
Inveniai Llc,
Prescient,
Elsevier,
Renaissthera,
Bert Labs,
Bioxcel, Llc,
Bioxcel Therapeutics, Inc.,
Global Antibiotic R&d Partnership (Gardp),
Vedtechbio,
Invea Therapeutics.
Alphameld Corporation's categories are Information Technology & Services
Alphameld Corporation's founding year is 2024
